25 Site Credits
SUBSCRIBE
You currently have 0 Site Credits in your account. Purchase Site Credits

Available in Packages/Products: PRESENT Complete Podiatric CME Online

Section: Wounds

The Latest Development in the Management of Chronic Diabetic Foot Ulcers: A Purified Reconstituted Bilayer Matrix

Charles Zelen, DPM, FACFAS

Charles Zelen, DPM, FACFAS examines the use of purified reconstituted bilayer matrix (PRBM) as a treatment for chronic diabetic foot ulcers. Dr Charles Zelen reviews a recent clinical study and outline the clinical benefits of purified reconstituted bilayer matrix to improve wound healing outcomes.

Completion (Credits: 1.25) CME (Credits: 1) CEU (Credits: 1.25)

  • CME Progress

  • Pre-Test

  • View Lecture ( Completion CME CEU Credits: )

    Lecture Transcript

  • Post-Test

    Requires: Pre-Test, View Lecture

  • Survey

    Requires: Pre-Test, View Lecture, PostTest

  • Certificate

    Requires: All Content Above

  • Certificate

    Requires: All Content Above

  • Certificate

    Requires: All Content Above
Method of Participation

Complete the 4 steps to earn your CE/CME credit:

  1. Complete the Pre-Test
  2. View the Lecture
  3. Complete the Quiz (Min. 70% Passing Score)
  4. Complete the program Survey
Goals and Objectives
  1. Understand the unique characteristics and scientific evidence around a novel advanced wound care matrix designed to treat difficult to heal wounds.
  2. Discuss purified reconstituted bilayer matrix clinical evidence in the management of chronic DFUs as compared to standard treatment options.
  3. Review clinical cases utilizing purified reconstituted bilayer matrix to improve wound healing outcomes.
  • Accreditation and Designation of Credits
  • Completion (Credits: 1.25)

    This lecture has been approved for the PRESENT Residency Education Online Curriculum by the PRESENT Curriculum Committee.

    Release Date: 03/23/2022 Expiration Date: 03/23/2023

  • CME (Credits: 1)

    PRESENT e-Learning Systems is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. PRESENT e-Learning Systems has approved this activity for a maximum of 1 continuing education contact hours

    Release Date: 03/23/2022 Expiration Date: 03/23/2023

  • CEU (Credits: 1.25)

    NURSING: Nurse CE is provided for this program through collaboration between Present e-Learning Systems and AffinityCE. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This activity provides 1.25 contact hours of nurse CE credit.

    Release Date: 03/23/2022 Expiration Date: 03/23/2023

  • Author

  • Charles Zelen, DPM, FACFAS

    ACFAS Fellowship Director
    Professional Education and Research Institutr
    Podiatry Section Chief
    Dept of Orthopedics
    HCA Lewis Gale Medical Center
    Roanoke, VA

  • System Requirements

  • To view Lectures online, the following specs are required:

    • PC Pentium-III class or better processor
    • 256MB minimum of RAM
    • Cable or DSL broadband Internet
    • Browsers must have javascript enabled. Most browsers have this feature enabled by default.
    • Adobe Acrobat Reader (Free) to print certificates
      • Supported Browsers:
      • Chrome
      • Firefox
      • IE 10+
      • Safari
      Supported Mobile OS:
      • Apple iOS 4.3+
      • Android 2.3+
      • Honeycomb 3.1+
      • Blackberry Playbook
  • Disclosure Information

  • It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.

    ---

    Charles Zelen is the Medical Director of PERI and has received research funds from Geistlich Pharma AG to complete clinical studies.

    This continuing education activity is managed and accredited by AffinityCE in cooperation with Present e-Learning Systems. AffinityCE and Present e-Learning Systems Staff, as well as Planners and Reviewers, have no relevant financial interests to disclose. Conflict of Interest when present was resolved through peer review of content by a non-conflicting reviewer.

    Commercial support was not received for this activity.